Fact CheckerSign in

NCT07844239Not yet recruiting

Direct Electrical Stimulation of Central Autonomic Network for Blood Pressure Control: a Mechanism Study

Source: ClinicalTrials.gov · Last updated 28 Sept 2026

Brief summary (registry, in English)

The primary objective of this research is to study direct electrical stimulation of central autonomic network for blood pressure control.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
20 (estimated)
First submitted
22 Sept 2026
Start date
1 Sept 2026
Primary completion date
31 Dec 2026
Lead sponsor
Xuanwu Hospital, Beijing
NCT number
NCT07844239

What you commit to

  • Study type: Interventional
  • Planned participants: 20
  • From 1 Sept 2026 to the primary completion date, 31 Dec 2026
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patients who are unable to cooperate due to mental disorders or other causes.
  • Patients with cardiac or pulmonary insufficiency.

Other

  • Patients with scalp electrode hematoma or sub-electrode effusion after intracranial electrode implantation, who are unable to receive electrical stimulation.
  • Patients with intracranial structural lesions (e.g., encephalomalacia foci, vascular malformations, space-occupying lesions, etc.).
  • Pregnant women.
  • Patients who have participated in other clinical trials within the past 3 months.
  • Patients who apply to withdraw from this clinical trial for any reason.
  • Patients with white coat effect are excluded.
  • Patients with low cerebrovascular risk assessed by cranial magnetic resonance imaging (MRI).

Who the study is looking for

  • Aged 18-60 years, with no gender restrictions.
  • Free from severe systemic diseases.
  • Patients who have undergone stereoelectroencephalography electrode implantation.
  • Patients who have been informed of potential risks, consented to participate in this study, and signed the informed consent form.
  • Daytime clinic blood pressure fluctuates within the following range: 90 mmHg \< systolic blood pressure \< 140 mmHg; 60 mmHg \< diastolic blood pressure \< 90 mmHg.

Age in the registry: 18 years to 60 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.